Effect of anti‐ IgE antibody, omalizumab, for refractory chronic spontaneous urticaria in an 8‐year‐old girl

Documenti analoghi

• Relapse rates and associated risk factors following omalizumab treatment in adolescents with chronic spontaneous urticaria
  di: Canan Caka, et al.
  Pubblicazione: (2025)
• Olipudase alfa IgE‐mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency
  di: Laura Fiori, et al.
  Pubblicazione: (2026)
• Evolving nodule on the lip of an 11‐year‐old girl
  di: Patrícia Amoedo, et al.
  Pubblicazione: (2024)
• A novel in‐frame deletion flanking exon 54 of the FBN1 gene in a Japanese girl with Marfan syndrome
  di: Toshihiko Mori, et al.
  Pubblicazione: (2025)
• Violaceous papules on the limbs of a 10‐year‐old girl
  di: Lauren G. Yi, et al.
  Pubblicazione: (2024)